(Q37856783)

24 August 2017

1 reference

title

Role of microRNAs in cardiac remodeling and heart failure (English)

1 reference

24 August 2017

0 references

0 references

1 reference

Douglas L Mann

2

0 references

author name string

Veli K Topkara

series ordinal

1

1 reference

24 August 2017

1 April 2011

1 reference

Cardiovascular Drugs and Therapy

24 August 2017

1 reference

24 August 2017

25

1 reference

24 August 2017

2

1 reference

24 August 2017

171-182

1 reference

Mechanisms and models in heart failure: the biomechanical model and beyond

24 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Control of stress-dependent cardiac growth and gene expression by a microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNAs play an essential role in the development of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

miRNA expression in the failing human heart: functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

miR-21: a small multi-faceted RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Myosin heavy chain gene expression in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Clinical applications of miRNAs in cardiac remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

The emerging role of microRNAs in cardiac remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

MiR423-5p as a circulating biomarker for heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6289-5

Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M109.036541

Identifiers

DOI

10.1007/S10557-011-6289-5

1 reference

24 August 2017

1 reference

PubMed ID

21431305